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would be in the interval of continued tobacco use from the time of
diagnosis until he or she ceased smoking, at which point he or she
would be placed in the interval of tobacco exposure cessation. In an
analysis in which each amputation in persons with multiple
amputations was considered a separate event, the amputation rate
was 84.3 (confidence interval 68.4 to 102.7 amputations/person
year  1000) in the interval of continued tobacco use versus 30.6
(confidence interval 17.5 to 49.6 amputations/person year 1000)
in the interval of discontinued tobacco use.
Survival in the TAO cohort was compared with the expected
survival in the U.S. population on the basis of age- and gender-
specific mortality rates (Fig. 2). Fifteen of 111 subjects died in a
median of 14.8 years of follow-up. The average age at death was
52.2 8.9 years. The survival of the TAO cohort was significantly
lower than that in the matched U.S. population (p  0.001 by
log-rank test). In univariate analysis, only older age at diagnosis
and decade of diagnosis were associated with an increased risk of
death. The risk of death was nearly identical in those subjects who
continued to use tobacco and those who quit. In multivariate
models, no variables were associated with risk of death.
The present TAO series is the first to report time-dependent
event rates for major or any amputation and death. Our analyses
have resulted in several novel observations: The risk of amputation
continues in ongoing smokers up to a median of 14.8 years (mean,
15.6 years) after initial diagnosis. The risk of amputation in
previous smokers is eliminated by 8 years after smoking cessation.
In contrast to previous studies, we report an excessive late mortality
in patients with TAO compared with the U.S. population (2,3).
Our data are limited in several ways. Not all patients had
systematic evaluation for thrombophilia and autoimmune disease.
The results of this study may not apply to patients with TAO in
the community. The cause of death is not known for most patients.
The ascertainment of nicotine cessation by chart review and survey
may not accurately reflect actual smoking cessation. Those with
mild addiction might be more likely than those with severe
addiction to complete the survey. Finally, a substantial fraction of
patients with TAO who reported smoking cessation may have
continued to smoke.
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Effect of Six Months’ Exercise Training on C-Reactive Protein Levels
in Healthy Elderly Subjects
To the Editor: Nonspecific markers of inflammation such as
C-reactive protein (CRP) are now recognized as major risk factors
for cardiovascular events. General population studies have reported
an inverse association between serum CRP levels and self-reported
physical activity or physical fitness (1,2). These studies suggested
that regular physical exercise might lower CRP levels by an
anti-inflammatory action. However, an alternative explanation is
that exercise lowers CRP levels by reducing total or abdominal fat.
We performed a randomized controlled trial to assess the effects of
six months’ regular exercise training on serum CRP levels and body
fat measured by dual-energy X-ray absorptiometry (DEXA) in a
healthy elderly population.
Healthy elderly subjects age 60 to 85 years were recruited from
the general population by newspaper advertisements. The exclu-
sion criteria included inability to undertake an exercise-training
program, current illness known to be associated with a systemic
inflammatory response, a history of hypertension or diabetes, any
current cardiovascular medication (including aspirin), or any evi-
dence of cardiovascular disease on physical examination, electro-
cardiography, treadmill exercise testing, or echocardiography. The
Figure 2. Observed survival in the thromboangiitis obliterans population
before and after tobacco cessation compared with the expected survival in
an age- and gender-matched U.S. population (controls). p  0.001 by
log-rank test.
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study protocol was approved by the University of Auckland ethics
committee, and all participants gave written informed consent.
Subjects were assigned randomly to either an exercise group or
a control group. The participants in the control group were asked
to maintain their usual level of physical activity. The exercise group
underwent six months’ exercise training, consisting of three super-
vised sessions and one unsupervised session each week. Exercise
intensity was monitored by heart rate response. The training
intensity was increased gradually so that by the fourth month,
participants were training for 45 min at a heart rate of 80% of their
current estimated maximum oxygen consumption (VO2max).
At the start and end of the study, the patients’ VO2max was
measured during graded treadmill exercise, body mass index (BMI)
was calculated (weight/height2 [kg/m2]), and total body fat and
trunk fat composition were determined by DEXA scanning using
a Lunar DPX-IQ scanner (GE Medical Systems, Waukesha,
Wisconsin). Venous blood samples were collected for measure-
ment of CRP levels at least 24 h after the last exercise session. In
participants with any illness or injury associated with an acute
phase response, blood sampling was delayed for two weeks. The
samples were stored at 80°C before being analyzed as a single
batch using a high-sensitivity assay (Dade Behring, Inc., Deerfield,
Illinois).
Because the distribution of CRP levels was skewed, natural-log-
transformed CRP was used for statistical analysis. The Pearson
correlation coefficient was used to assess the association between
natural-log-transformed CRP and other baseline variables.
Changes in CRP levels and other variables were compared between
groups using a Mann-Whitney U test. All analyses were performed
using SAS Release 8.0 Software (SAS Institute Inc., Cary, North
Carolina).
Two participants were lost to follow-up, leaving a final cohort
for analysis of 30 exercise subjects and 31 control subjects. Analyses
were performed on an intention-to-treat basis and included all
subjects with follow-up data. A sensitivity analysis (excluding four
dropouts from the exercise program) did not alter the study
findings.
The baseline characteristics of the exercise and control groups
were similar (Table 1). Greater physical fitness (VO2max) was
associated with a lower BMI (r  0.27, p  0.03), less body fat
(r0.61, p 0.001), and less trunk fat (r0.55, p 0.001).
C-reactive protein levels correlated with measures of adiposity,
including the BMI (r  0.40), body fat percentage (r  0.46), and
trunk fat percentage (r 0.48, p 0.001 for all). In contrast, there
was only a weak trend toward lower CRP levels with greater fitness
(r  0.22, p  0.09).
At six months, there was an 18% improvement in cardiorespi-
ratory fitness in the exercise group and no change in the control
group (Table 2). There were no significant changes in body weight,
body fat percentage, lipid profile, or serum glucose levels in either
group. Considerable individual variability in CRP levels existed
between baseline and six months but, on average, serum CRP
levels did not change in either group. In addition, no association
between changes in fitness and changes in CRP levels during the
six-month trial was found. The results were similar for men and
women.
In this study, six months’ exercise training in healthy elderly
participants did not lower serum CRP levels despite a significant
improvement in their cardiorespiratory fitness. This finding con-
trasts with those of several large epidemiologic studies that
reported an inverse association between serum CRP levels and
regular physical activity (1,3,4) and/or physical fitness (2,5). There
are several possible explanations for this difference. The association
between exercise and inflammatory markers observed in epidemi-
ologic studies may not be causal. Poor health of any severity may
cause inflammation, as well as decreasing regular exercise and
physical fitness. Alternatively, the cumulative effects of exercise
may influence serum CRP levels over the course of many years,
although not by shorter-term changes in exercise levels. This
possibility is consistent with the hypothesis that physical exercise
acts predominantly by reducing body fat. It is supported by the
strong inverse association between physical fitness and body fat
percentage observed in this study and the results of clinical trials
that have reported reductions in CRP levels after weight loss (6).
Although observational studies that reported an association be-
Table 1. Baseline Characteristics
Control Group
(n  31)
Exercise Group
(n  30)
Male gender (%) 14 (45) 13 (43)
Age (yrs) 66  4 67  5
Current smoker (%) 1 (3) 1 (3)
BMI (kg/m2) 26  4 25  3
Body fat (%) 33  9 33  10
Trunk fat (%) 18  5 17  5
VO2max (ml/kg/min) 28  8 26  6
Glucose (mg/dl) 90  16 94  13
LDL cholesterol (mg/dl) 139  31 131  29
CRP (mg/l) 1.5 [0.7 to 2.1]* 1.6 [0.5 to 2.9]*
*Numbers in brackets indicate interquartile range.
BMI  body mass index; CRP  C-reactive protein; LDL  low-density
lipoprotein; VO2max  maximum oxygen consumption during treadmill exercise.
Table 2. Changes in Fitness, BMI, Body Fat, and Serum Levels of CRP, Glucose, and Lipids Between Baseline and Six Months
Exercise Group Control Group Exercise vs.
Control
p ValueMedian Change* % Change* Median Change* % Change*
VO2max (ml/kg/min) 3.7 [1.3 to 8.3] 18 [4 to 37] 0.05 [2.2 to 3.0] 0 [7 to 14] 0.004
BMI (kg/m2) 0.14 [0.6 to 0.3] 1 [3 to 1] 0.07 [0.07 to 0.2] 0 [3 to 1] 0.98
Body fat (%) 0.7 [2.8 to 0.1] 2 [10 to 0] 0 [1.7 to 1.3] 0 [7 to 4] 0.43
Trunk fat (%) 0.9 [1.7 to 0.5] 6 [10 to 2] 0.8 [1.9 to 0.6] 4 [15 to 3] 0.54
CRP (mg/l) 0.12 [0.8 to 0.3] 6 [34 to 33] 0.06 [0.4 to 0.5] 4 [30 to 52] 0.30
Glucose (mg/dl) 0.9 [9.0 to 5.4] 1 [9 to 7] 1.8 [10.8 to 5.4] 2 [11 to 7] 0.95
LDL cholesterol (mg/dl) 2.2 [4.5 to 2.3] 6 [10 to 8] 3.4 [5.7 to 0.0] 7 [15 to 0] 0.21
Changes are six-month levels minus baseline levels. *Numbers in brackets indicate interquartile range.
Abbreviations as in Table 1.
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tween physical activity or fitness and serum CRP levels adjusted for
BMI or waist girth (1,2), these measures of body fat are relatively
imprecise, and residual confounding is possible. In the current
study, the more precise DEXA scanning method was used to
measure body fat and trunk fat. These DEXA measures correlated
more strongly than BMI with both CRP levels and physical fitness.
A limitation of the current study was variability in serum CRP
levels. This variability reduced the statistical power of the study
and, therefore, a small effect of improved physical fitness on CRP
levels, independent of changes in body fat, cannot be excluded.
Few previous studies have reported the effects of exercise training
on CRP levels. Mattusch et al. (7) found a significant reduction in
CRP levels after nine months of marathon training in 12 athletes.
Smith et al. (8) reported a trend toward lower CRP levels in 43
volunteers after six months of exercise training. These studies did
not include a control group and did not measure body fat. In
conclusion, our findings suggest that the association between
greater physical fitness and lower serum CRP levels is explained, at
least in part, by long-term regular exercise reducing body fat.
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Gender as a Risk Factor in Young, Not in Old, Women Undergoing
Coronary Artery Bypass Grafting
To the Editor: Women have a higher early mortality after coro-
nary artery bypass grafting (CABG) compared with men in most
studies (1,2). The influence of gender and age on early mortality
and age- and gender-dependent risk factors have only been
analyzed in a single U.S. study (1). Because demographic variables
and therapeutic strategies may be different in the U.S. and Europe,
analyses from European countries also are needed.
Patients undergoing CABG are increasingly older, and women
undergoing CABG are older than men. The risk for myocardial
infarction (MI) differs in women and men, as well as the pattern of
coronary artery disease and myocardial remodeling. Acute MI has
a worse prognosis, especially in younger women (3). Similar risk
factors may influence mortality after MI and CABG.
We therefore analyzed in our large patient cohort whether early
outcome after CABG was worse in women, whether the interaction
between female gender and mortality was age dependent, and which
preoperative parameters acted in a gender-specific manner. Using on
our quality control database, we analyzed 17,528 consecutive patients
(4,278 women and 13,250 men) who underwent CABG in the
Deutsches Herzzentrum Berlin from 1993 to 2001. Standard statis-
tical procedures, including multivariate testing, receiver-operated
command analysis, and the Breslow-Day test, were used (1,4).
The percentage of women who underwent CABG increased with
age, from 14% in the cohort younger than 50 years to 49% in that
cohort older than 80 years (Fig. 1). In the mean, women had better
left ventricular ejection fraction (LVEF) than men (55% women vs.
53% men); previous MI and previous CABG were less frequent (55%
vs. 59% and 20% vs. 22%, respectively), and hypertension and diabetes
(77% vs. 67% and 39% vs. 27%, respectively) were more frequent. In
contrast, non-elective surgery was more frequent in women than in
men (31% vs. 27%; p  0.001 for all).
Mortality in women was significantly higher than in men, with
the greatest differences in the youngest and no differences in the
older age groups (Fig. 2). Female gender was an independent risk
factor for mortality (hazard ratio 1.236; 95% confidence interval
1.008 to 1.56). In addition, age, impaired LVEF, and number of
diseased vessels were independent predictors of early mortality in
women. In men, priority of surgery and renal dysfunction were
significant predictors of outcome.
The optimal cutoff value for age as a predictor of mortality was
calculated as 70.5 years by receiver-operated command analysis. In
the younger cohort, gender, age, number of affected vessels, LVEF,
priority of surgery, and renal dysfunction were predictors of
outcome. Previous MI was a significant risk factor in younger
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